Install
Stay informed on the latest biopharmaceutical news, trends, and developments in Asia Pacific with BioPharma APAC. BioPharma Asia ( APAC ) provides in-depth analysis, insights, and expert commentary on drug development, regulatory updates, and industry partnerships in the region.
- 60articles · 30d
- 5+ hour agolatest article
- Aug 15, 2026earliest in window
- 97%with images
- 212avg words
- Medical 45
- Health & Wellness 36
- Economy, Business & Finance 23
- Health 20
- Business & Industrial 19
- Science & Technology 17
- Science & Nature 7
- Finance & Business 6
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Bausch + Lomb Secures European CE Mark for Next-Generation SeeLyra Femtosecond Laser
5+ hour, 25+ min ago (127+ words) 14 September 2026 | Monday | News “Premium surgery success begins with precise surgical preparation of the eye,” said José Manuel Larrosa, MD, University of Zaragoza, Spain. “SeeLyra will help me to achieve this consistently on my terms, while fitting seamlessly and efficiently into…...
Exegenesis Bio, Modalis Partner to Advance CRISPR-Based DMD Therapy MDL-201
5+ hour, 35+ min ago (68+ words) 14 September 2026 | Monday | News The financial impact of this research collaboration on Modalis' results for the current fiscal year is expected to be immaterial, and there is no revision to the earnings forecast at this time. Two Chairs, 11,000 Kilometres Apart: The…...
BGI Genomics Unveils Digital Life Twin Framework for Predictive Health Management
3+ day, 5+ hour ago (75+ words) 11 September 2026 | Friday | News Anchored by the Life Index system and built on precise risk stratification and systematic health assessments, this model connects upstream to BGI Genomics' full portfolio of multi-omics tests and interventions while empowering downstream healthcare providers and health…...
Kelun-Biotech’s Twice-Yearly Asthma Candidate SKB378 Advances into Phase III
4+ day, 5+ hour ago (143+ words) 10 September 2026 | Thursday | News Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company") announced that its partner, Windward Bio, has reported positive interim results from the Phase 2 portion of the POLARIS-1 clinical trial, which evaluates twice-yearly dosing of SKB378/WIN378 in asthma. The…...
HaemaLogiX Doses First Patient with KMCAR T-Cell Therapy in Phase 1 Multiple Myeloma Trial
1+ week, 5+ day ago (207+ words) 27 August 2026 | Thursday | News HaemaLogiX Ltd is pleased to announce another milestone in its ongoing Phase 1 KOALA trial, with the first patient having been safely treated with KMCAR™ T-cell therapy. Following an initial infusion, the patient demonstrated that the treatment was…...
DualityBio, Genentech Ink $1B-Plus Deal to Develop Next-Generation ADCs Against Drug-Resistant Tumours
2+ week, 5+ hour ago (234+ words) 31 August 2026 | Monday | News DUALITYBIO Inc. announced that it has entered into a collaboration and license agreement with Genentech, a member of the Roche Group, to develop next-generation antibody-drug conjugates ("ADCs") built on the Company's proprietary DualityBio Unique Payload Antibody Conjugate…...
The Biological Age Business
2+ week, 4+ day ago (577+ words) 26 August 2026 | Wednesday | Analysis Figure 1. Regulatory classification of biological age test categories against market, as at 17 August 2026. Cells record the published instrument in force, not enforcement practice. Anyone with a view has until that Friday evening to put it on the…...
Thermo Fisher Launches First Orbitrap Isora Mass Spectrometers for Molecular-Level Isotope Analysis
2+ week, 5+ day ago (79+ words) 25 August 2026 | Tuesday | News New Orbitrap Isora workflow integrates mass spectrometry, Vanquish Duo UHPLC System and Isotope Discoverer Software to bring molecular-level isotope ratio analysis to more researchers worldwide The Orbitrap Isora workflow expands what researchers can investigate with isotope ratio…...
Taiwan’s Anbogen Partners University of Tokyo to Advance ABT-301 Across Solid Tumours
2+ week, 6+ day ago (742+ words) BioPharma APAC - Taiwan’s Anbogen Partners University of Tokyo to Advance ABT-301 Across Solid Tumours 24 August 2026 | Monday | News Anbogen Therapeutics Inc. (TPEx: 7784) ("Anbogen" or the "Company"), a clinical-stage precision oncology company, announced that it has entered into a Collaborative Research Agreement…...
Akeso Secures China Clinical Trial Clearance for B7-H3 ADC AK157D1
2+ week, 6+ day ago (172+ words) 24 August 2026 | Monday | News AK157D1 is the third next-generation ADC candidate from Akeso to enter clinical development, following AK146D1 (TROP2/Nectin-4 ADC) and AK138D1 (HER3 ADC). The clearance further advances the Company's IO2.0 + ADC2.0 strategy and expands its broad innovative oncology pipeline. B7-H3 is highly expressed in a broad…...